EnteroMedics Announces First US Commercial Implant of vBloc® Neurometabolic Therapy System
Raymond Kester and the EnteroMedics team achieved the first commercial implant [of vBloc] at Tufts University Medical Center. The procedure was performed by Dr. Sunny Shah, one of our clinical investigators and was attended by Mike Bierk, Director of Training and Chip Freeman, Regional Sales Director for the North East from EnteroMedics. The procedure went flawlessly, and Howard, our first commercial patient went home within a couple of hours. He returned to work on Monday, and is reportedly doing wonderfully.
Howard’s journey to becoming a vBloc patient was a shining example of the commercial patient acquisition, and access programs working as designed.
See all the other press coverage here: